Now, tumor promotion in human cancer is understood as a disease that affects humans in two ways: the up-regulation of proinflammatory cytokines and chemokines and the inhibition of PP2A by PP2A inhibitors (Fujiki and Suganuma 1993; Fujiki et al. 2013). The gene discussed is PTPA; the disease is neoplasm.